Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

LTA4H association with montelukast response in early and late-onset asthma

View ORCID ProfileCyrielle Maroteau, View ORCID ProfileAntonio Espuela-Ortiz, View ORCID ProfileEsther Herrera-Luis, View ORCID ProfileSundararajan Srinivasan, Fiona Carr, Roger Tavendale, Karen Wilson, View ORCID ProfileNatalia Hernandez-Pacheco, James D. Chalmers, View ORCID ProfileSteve Turner, Somnath Mukhopadhyay, View ORCID ProfileAnke-Hilse Maitland-van der Zee, View ORCID ProfileEsteban G. Burchard, View ORCID ProfileMaria Pino-Yanes, View ORCID ProfileSimon Young, View ORCID ProfileGlenda Lassi, View ORCID ProfileAdam Platt, View ORCID ProfileColin N. A. Palmer, on behalf of the PiCA consortium
doi: https://doi.org/10.1101/2020.10.05.20206847
Cyrielle Maroteau
1Centre for Genomics Research, Discovery Science, BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
2Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cyrielle Maroteau
  • For correspondence: cyrielle.maroteau@astrazeneca.com
Antonio Espuela-Ortiz
3Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antonio Espuela-Ortiz
Esther Herrera-Luis
3Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Esther Herrera-Luis
Sundararajan Srinivasan
2Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sundararajan Srinivasan
Fiona Carr
2Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Tavendale
2Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Wilson
2Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Hernandez-Pacheco
3Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain
4Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalia Hernandez-Pacheco
James D. Chalmers
5Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Turner
6Child Health, University of Aberdeen, Aberdeen, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Steve Turner
Somnath Mukhopadhyay
7Academic Department of Pediatrics, Brighton and Sussex Medical School, Royal Alexandra Children’s Hospital, Brighton, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anke-Hilse Maitland-van der Zee
8Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands
9Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, the Netherlands
10Department of Pediatric Respiratory Medicine and Allergy, Emma’s Children Hospital, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anke-Hilse Maitland-van der Zee
Esteban G. Burchard
11Department of Medicine, University of California, San Francisco, San Francisco, California, United States
12Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Esteban G. Burchard
Maria Pino-Yanes
3Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain
13CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain
14Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Pino-Yanes
Simon Young
15BioPharmaceutical Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon Young
Glenda Lassi
16Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Glenda Lassi
Adam Platt
16Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam Platt
Colin N. A. Palmer
2Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Colin N. A. Palmer
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Leukotrienes play a central pathophysiological role in both pediatric and adult asthma. However, 35% to 78% of asthmatics do not respond to leukotriene inhibitors. To test the role of the LTA4H regulatory variant rs2660845 and age of asthma onset in response to montelukast in ethnically diverse populations.

We identified and genotyped 3,594 asthma patients treated with montelukast (2,514 late-onset and 1,080 early-onset) from seven cohorts (UKBiobank, GoSHARE, BREATHE, Tayside RCT, PAGES, GALA II and SAGE). Individuals under montelukast treatment experiencing at least one exacerbation in a 12-month period were compared against individuals with no exacerbation, using logistic regression for each cohort and meta-analysis.

While no significant association was found with European late-onset subjects, a meta-analysis of 523 early-onset individuals from European ancestry demonstrated the risk of experiencing asthma exacerbations in the G allele carriers’ group (AG or GG), despite montelukast treatment, was increased (odds-ratio=3.27, 95%confidence interval: 0.98–10.93, I2=69%, p=0.05) compared to those in the AA group. When meta-analyzing with other ethnic groups, no significant increased risk of asthma exacerbations was found (OR=1.69, 95% CI: 0.56-5.09, I2=84.81%, p=0.35).

Our study demonstrates that genetic variation in LTA4H, together with timing of asthma onset, may contribute to variability in montelukast response. Europeans individuals with early-onset (≤18y) carrying the rs2660845 G allele have increased risk of exacerbation under montelukast treatment, presumably due to the up-regulation of LTA4H activity. These findings support a precision medicine approach for the treatment of asthma with montelukast.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

BREATHE was funded by Scottish Enterprise Tayside, the Gannochy trust, the Perth and Kinross City Council and Brighton and Sussex Medical School. Tayside RCT is supported by Merck, Sharpe and Dohme, United Kingdom. PAGES was funded by the Chief Scientist Officer for Scotland. The SHARE Bioresource (GoSHARE) and SHARE have ongoing funding from NHS Research Scotland and established by funding from The Wellcome Trust Biomedical Resource [Grant No. 099177/Z/12/Z]. The GoDARTS study was funded by The Wellcome Trust (Award 072960 and 084726) and the UK Medical Research Council (Award G0601261). Genotyping of PAGES was funded by grant AC15/00015 by Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES) and European Community (EC) within the Active and Assisted Living (AAL) Programmed framework, and by the SysPharmPedia grant. The SysPharmPediA consortium is supported by ZonMW [project number: 9003035001], the Ministry of Education, Science and Sport of the Republic of Slovenia [contract number C330-16-500106], the German Ministry of Education and Research (BMBF) [project number FKZ 031L0088], Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES) and European Community (EC) within the Active and Assisted Living (AAL) Programme framework [award numbers AC15/00015 and AC15/00058] under the frame of the ERACoSysMed JTC-1 Call. Genotyping service was carried out at CEGEN-PRB3-ISCIII; supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and European Regional Development Fund (ERDF). GALA II and SAGE were supported by the NHLBI of the United States National Institutes of Health (NIH) through grants R01HL117004 and X01HL134589. Additional study enrolment was supported by the Sandler Family Foundation, the American Asthma Foundation, the Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation, the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II, and the National Institute of Environmental Health Sciences (NIEHS) grant R01ES015794. The generation, cleaning, quality control, and analysis of GALA II and SAGE data was funded by the NHLBI grants R01HL128439, R01HL135156, R01HL141992, and R01HL141845; the NIEHS grant R21ES24844; the National Institute on Minority Healthand Health Disparities (NIMHD) P60MD006902, R01MD010443, and R56MD013312; the National Institute of General Medical Sciences (NIGMS) grant RL5GM118984; the Tobacco-Related Disease Research Program under Award Numbers 24RT-0025 and 27IR-0030; and the National Human Genome Research Institute (NHGRI) U01HG009080 to EGB. CM is supported by an AstraZeneca postdoctoral fellowship. EH-L is supported by a fellowship (PRE2018-083837) from the Spanish Ministry of Science, Innovation and Universities. MP-Y is funded by the Ramon y Cajal Program by the Spanish Ministry of Economy, Industry and Competitiveness (RYC- 2015-17205). N.H-P was supported by a fellowship (FI16/00136) from Instituto de Salud Carlos III (ISCIII) and co-funded by the European Social Funds from the European Union (ESF) ESF invests in your future.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The studies included in this article comply with the Declaration of Helsinki, and locally appointed ethics committee have approved respective research protocols and informed consent has been obtained from the subjects. PAGES was approved by the Cornwall and Plymouth Research Ethics Committee (Plymouth, United Kingdom). GoSHARE, BREATHE and Tayside RCT was approved by the Tayside Committee on Medical Research Ethics (Dundee, United Kingdom). The UKBiobank was approved by the National Research Ethics Committee.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Take home message: Our study add to the growing evidence of age of asthma onset as a robust clinical biomarker and suggests using it and rs2660845 status as basis of a precision medicine strategy to select patients most likely to benefit from montelukast treatment.

Data Availability

Data available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 06, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
LTA4H association with montelukast response in early and late-onset asthma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
LTA4H association with montelukast response in early and late-onset asthma
Cyrielle Maroteau, Antonio Espuela-Ortiz, Esther Herrera-Luis, Sundararajan Srinivasan, Fiona Carr, Roger Tavendale, Karen Wilson, Natalia Hernandez-Pacheco, James D. Chalmers, Steve Turner, Somnath Mukhopadhyay, Anke-Hilse Maitland-van der Zee, Esteban G. Burchard, Maria Pino-Yanes, Simon Young, Glenda Lassi, Adam Platt, Colin N. A. Palmer, on behalf of the PiCA consortium
medRxiv 2020.10.05.20206847; doi: https://doi.org/10.1101/2020.10.05.20206847
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
LTA4H association with montelukast response in early and late-onset asthma
Cyrielle Maroteau, Antonio Espuela-Ortiz, Esther Herrera-Luis, Sundararajan Srinivasan, Fiona Carr, Roger Tavendale, Karen Wilson, Natalia Hernandez-Pacheco, James D. Chalmers, Steve Turner, Somnath Mukhopadhyay, Anke-Hilse Maitland-van der Zee, Esteban G. Burchard, Maria Pino-Yanes, Simon Young, Glenda Lassi, Adam Platt, Colin N. A. Palmer, on behalf of the PiCA consortium
medRxiv 2020.10.05.20206847; doi: https://doi.org/10.1101/2020.10.05.20206847

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (433)
  • Anesthesia (99)
  • Cardiovascular Medicine (946)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (420)
  • Epidemiology (8978)
  • Forensic Medicine (4)
  • Gastroenterology (419)
  • Genetic and Genomic Medicine (1947)
  • Geriatric Medicine (190)
  • Health Economics (401)
  • Health Informatics (1327)
  • Health Policy (657)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (419)
  • Infectious Diseases (except HIV/AIDS) (10793)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1824)
  • Nursing (109)
  • Nutrition (272)
  • Obstetrics and Gynecology (352)
  • Occupational and Environmental Health (470)
  • Oncology (997)
  • Ophthalmology (297)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (579)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1895)
  • Public and Global Health (4117)
  • Radiology and Imaging (675)
  • Rehabilitation Medicine and Physical Therapy (366)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (80)